United Therapeutics
UTHR
UTHR
319 hedge funds and large institutions have $3.63B invested in United Therapeutics in 2019 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 103 increasing their positions, 94 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
319
Holders Change
+17
Holders Change %
+5.63%
% of All Funds
6.3%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
65
Increased
103
Reduced
94
Closed
41
Calls
$23.6M
Puts
$22.5M
Net Calls
+$1.05M
Net Calls Change
-$812K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$44M |
| 2 |
Renaissance Technologies
New York
|
+$29.3M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$20.1M |
| 4 |
BlackRock
New York
|
+$19.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$51.1M |
| 2 |
Millennium Management
New York
|
-$49.5M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$31.9M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$21.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20.1M |